Riskpilot← Back to searchSign inGet full accessZusmanis i Borserud AB
ABActiveOrg 5590509633Borserudsbacken 221Medical specialists activities · NACE 8622Est. 20162 employees
Revenue 2025
SEK 3M
+15% vs 2024
EBITDA margin
48.4%
+29% vs 2024
Equity ratio
52.4%
Financial strength
Net profit 2025
SEK 927K
+50% vs 2024
| Revenue | SEK 3M | +15% |
| EBITDA | SEK 1,4M | +29% |
| Net profit | SEK 927K | +50% |
| Total assets | SEK 8,3M | +21% |
| Equity | SEK 4,3M | +20% |
| Employees | 2 | — |
Legal name
Zusmanis i Borserud AB
Org number
5590509633
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
11 februari 2016
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkarpraktik, uthyrning, förmedling av sjukvårdspersonal samt även uthyrning av stugor. Handel med konst, antikviteter och kuriosa samt annan därmed förenlig verksamhet.
Address
Borserudsbacken 221
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 194 | 3 127 | 2 742 | 2 587 | 2 974 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 170 | 1 721 | 1 486 | 1 113 | 1 439 |
| Depreciation & amort. | −66 | −67 | −67 | −96 | −99 |
| EBIT | 1 104 | 1 654 | 1 419 | 1 017 | 1 340 |
| Net financials | −1 | — | — | −2 | −1 |
| Profit before tax | 832 | 1 173 | 1 050 | 797 | 1 188 |
| Tax | −179 | −247 | −226 | −180 | −261 |
| Net profit | 653 | 926 | 824 | 617 | 927 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 165 | 5 438 | 6 291 | 6 812 | 8 272 |
| Equity | 1 808 | 2 554 | 3 188 | 3 609 | 4 332 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 308 | 1 355 | 1 205 | 1 086 | 1 673 |
| Total debt | 1 308 | 1 355 | 1 205 | 1 086 | 1 673 |
EBITDA margin
48.4%
This company
15.8%
Market median
+206% vs market
20212025
Equity ratio
52.4%
This company
38.2%
Market median
+37% vs market
20212025
Return on equity
21.4%
This company
18.4%
Market median
+16% vs market
20212025
Net profit margin
31.2%
This company
8.1%
Market median
+285% vs market
20212025
Asset turnover
0.36×
This company
1.12×
Market median
-68% vs market
20212025
Debt / equity
0.91×
This company
0.62×
Market median
+47% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Zusmanis i Borserud AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anh Mai Thi Le | Chief Executive Officer | 0 companies |
| Rauno Toivo Juhani Liimatta | Deputy Board Member | 0 companies |